129 related articles for article (PubMed ID: 7128193)
1. The effects of gliclazide on platelet function in patients with diabetes mellitus.
Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
[TBL] [Abstract][Full Text] [Related]
2. [Long-term effect of gliclazide on platelet function in diabetes].
Pan CY
Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
[No Abstract] [Full Text] [Related]
3. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
[TBL] [Abstract][Full Text] [Related]
4. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the effects of some sulphonylureas on platelet function.
King JB; Kalk WJ; Vinik AI; Jackson WP; Bracher M; Jacobs P
S Afr Med J; 1977 Jan; 51(5):124-6. PubMed ID: 322325
[TBL] [Abstract][Full Text] [Related]
6. Sulfonylureas and platelet function.
Klaff LJ; Kernoff L; Vinik AI; Jackson WP; Jacobs P
Am J Med; 1981 Mar; 70(3):627-30. PubMed ID: 6782875
[TBL] [Abstract][Full Text] [Related]
7. Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets.
Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M
Thromb Res; 1981 Jan 1-15; 21(1-2):103-10. PubMed ID: 7233394
[No Abstract] [Full Text] [Related]
8. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
Khanolkar MP; Morris RH; Thomas AW; Bolusani H; Roberts AW; Geen J; Jackson SK; Evans LM
Atherosclerosis; 2008 Apr; 197(2):718-24. PubMed ID: 17765245
[TBL] [Abstract][Full Text] [Related]
9. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
[No Abstract] [Full Text] [Related]
10. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
Paton RC; Kernoff PB; Wales JK; McNicol GP
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
[No Abstract] [Full Text] [Related]
12. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo. Effect of the sulfonyl urea derivatives, glibenclamide, gliclazide, and HB180, as well as the carboxylic acid derivative, meglitinide.
Gastpar H; Weissgerber PW; Enzmann F; Zoltobrocki M
Res Exp Med (Berl); 1982; 180(1):75-84. PubMed ID: 6805052
[TBL] [Abstract][Full Text] [Related]
14. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
Arfors KE; Bergqvist D; Tangen O
Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory action of gliclazide on platelet functions.
Mizuno A; Yano M; Isobe J; Shima K
Diabetes Res Clin Pract; 1989 Aug; 7(2):141-7. PubMed ID: 2505994
[TBL] [Abstract][Full Text] [Related]
16. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
[TBL] [Abstract][Full Text] [Related]
18. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
Chan TK; Chan V; Teng CS; Yeung RT
Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
[TBL] [Abstract][Full Text] [Related]
19. Hemobiological activity of gliclazide in diabetes mellitus.
Ziegler O; Drouin P
Diabetes Res Clin Pract; 1991; 14 Suppl 2():S83-9. PubMed ID: 1794271
[TBL] [Abstract][Full Text] [Related]
20. Effects of sulfonylurea agents on platelet arachidonic acid metabolism; study on platelet homogenates.
Satoh K; Ozaki Y; Yatomi Y; Kume S
Biochem Pharmacol; 1994 Aug; 48(5):1053-5. PubMed ID: 8093094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
